The Ohio Cardiovascular & Diabetes Health Collaborative (Cardi-OH) is a statewide initiative of health care professionals who share knowledge to improve Medicaid patient outcomes and eliminate health disparities across Ohio.
Describe the epidemiology of obesity and its intersection with diabetes.
Understand the role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT2i) for diabetes and weight loss.
Prescribe effective and necessary lifestyle modifications as an accompaniment to pharmacological therapy.
VisitCardi-OH.orgto read more about the collaborative and our latest best practices.
Sharing best practices to improve
cardiovascular and diabetes health
The Ohio Cardiovascular and Diabetes Health Collaborative is funded by the Ohio Department of Medicaid and administered by the Ohio Colleges of Medicine Government Resource Center. The views expressed in this presentation are solely those of the authors and do not represent the views of the state of Ohio or federal Medicaid programs.